2026 Apr:353:151235
Not for human consumption, medical, or veterinary use
Long-term success will depend on clinical differentiation, real-world evidence, payer value, patient support programs, adherence tools, physician education, and clear positioning across obesity, type 2 diabetes, cardiovascular risk and metabolic syndrome
Need labs
Many patients who regain weight post-surgery wonder whether GLP-1 receptor agonists like semaglutide are safe to use, and the answer requires careful medical consideration based on your individual surgical history and current health status
Your titration schedule is tailored to your individual tolerance and genetic predispositions, not a one-size-fits-all approach